Reduce Tobacco Use in People Living With HIV in Switzerland

Recruiting N/A Interventional Study
HIV Smoking
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
972 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Signed informed consent for the data collection and participation in the SHCS (Cohort consent). * Signed informed consent to be randomized to future interventions (Randomization consent). * Age 18 years or older. * Smoked one or more tobacco cigarettes per day (smoking status …
Contacts

Matthias Briel, Prof.

+ 4161 265 3815

matthias.briel@usb.ch

CONTACT

Christof Schönenberger, Dr.

ChristofManuel.Schoenenberger@usb.ch

CONTACT